Enovix (NASDAQ:ENVX) Shares Down 8.7% – What’s Next?

Enovix Corporation (NASDAQ:ENVX)’s stock price traded down 8.7% during trading on Tuesday . The company traded as low as $5.24 and last traded at $5.1290. 814,270 shares traded hands during trading, a decline of 87% from the average daily volume of 6,403,803 shares. The stock had previously closed at $5.62.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Wall Street Zen raised shares of Enovix from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 16th. Wells Fargo & Company set a $6.00 price objective on Enovix in a report on Thursday, March 12th. Bank of America started coverage on Enovix in a research note on Thursday, March 12th. They issued a “neutral” rating and a $6.00 price objective on the stock. JPMorgan Chase & Co. cut Enovix from a “neutral” rating to an “underweight” rating in a report on Wednesday, May 6th. Finally, TD Cowen restated a “buy” rating on shares of Enovix in a research report on Thursday, May 14th. Seven analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $12.64.

Enovix Price Performance

The company has a debt-to-equity ratio of 2.14, a quick ratio of 10.65 and a current ratio of 10.97. The company’s 50 day moving average price is $6.72 and its 200 day moving average price is $6.53. The company has a market cap of $1.10 billion, a price-to-earnings ratio of -6.11 and a beta of 2.26.

Enovix (NASDAQ:ENVX) last announced its earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The business had revenue of $7.60 million during the quarter, compared to analysts’ expectations of $6.95 million. During the same quarter last year, the company posted ($0.15) EPS. The firm’s revenue for the quarter was up 49.1% on a year-over-year basis. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. On average, equities research analysts predict that Enovix Corporation will post -0.79 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Enovix

Large investors have recently bought and sold shares of the business. Parallel Advisors LLC raised its position in Enovix by 51.9% in the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock valued at $39,000 after purchasing an additional 1,342 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in shares of Enovix during the fourth quarter worth $30,000. CWM LLC grew its holdings in shares of Enovix by 95.4% during the fourth quarter. CWM LLC now owns 6,081 shares of the company’s stock worth $44,000 after purchasing an additional 2,969 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Enovix in the third quarter valued at $80,000. Finally, Bowman & Co S.C. acquired a new stake in shares of Enovix in the fourth quarter valued at $73,000. 50.92% of the stock is currently owned by institutional investors.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.